National Cancer Institute Selects CambridgeSoft to Support Chemical Biology Consortium

CAMBRIDGE, Mass.–The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium. The ChemBioOffice Enterprise suite will allow members of the Consortium to manage and share vital scientific information.

“Using state-of-the-art communication, data-sharing and project management tools, the Chemical Biology Consortium will affect a paradigm shift in the use of public-private partnerships to translate knowledge from leading academic institutions into ground-breaking new drug candidates for patients with cancer.” stated the National Cancer Institute.

“CambridgeSoft is proud to have been selected as the Informatics platform for the Chemical Biology Consortium.” said Michael G. Tomasic, President and CEO of CambridgeSoft. “The CambridgeSoft ChemBioOffice Enterprise suite will provide a state-of-the-art scientific data management and decision support platform on which the Chemical Biology Consortium can build and share knowledge to help develop the next generation of cancer therapies. “

A public solicitation has been published by NCI inviting collaborative members to join the consortium and may be found at:

https://www.fbo.gov/index?s=opportunity&mode=for m&id=5b49c24c70ea6fc5fa8632d32c232c23&tab=core&_cview=1 (Due to the length of this URL, it may be necessary to copy and paste it into your Internet browser’s URL address field. You may also need to remove an extra space in the URL if one exists.)